Enomoto A, Bradley W G
J Neurol Neurosurg Psychiatry. 1978 May;41(5):404-7. doi: 10.1136/jnnp.41.5.404.
A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 microgram/10 g body weight) and low dose gold (5 microgram/10 g body weight) with saline-injected control animals was made, all injections being given three times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 microgram of gold/10 g body weight) also showed no therapeutic benefit.
报道了一项关于硫代苹果酸金钠作为抗蛋白酶药物治疗小鼠肌肉萎缩症的试验。对高剂量(25微克/10克体重)和低剂量金(5微克/10克体重)的小鼠与注射生理盐水的对照动物进行了盲法对照比较,所有注射均每周进行三次。每周对小鼠的体重和功能能力进行评估。各实验组之间未观察到显著差异。一项极高剂量金疗法(500微克金/10克体重)的试验也未显示出治疗效果。